New York, US, [24-December-2025]-  The Inhalable Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. This growth is primarily driven by an increasing prevalence of chronic respiratory diseases, advancements in inhalation technology, and a rising demand for effective therapeutic options....